Medicare, Medicaid and CLIA Programs:

Federal Register: August 11, 2010 (Volume 75, Number 154)

Notices

Page 48698

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr11au10-71

Page 48698

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

CMS-2363-N

Medicare, Medicaid and CLIA Programs; COLA (Formerly the

Commission on Office Laboratory Accreditation) Voluntary Withdrawal

From the Specialty of Pathology

AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.

ACTION: Notice.

SUMMARY: This notice announces COLA's voluntary withdrawal from the specialty of Pathology. COLA is an accreditation organization for clinical laboratories under the Clinical Laboratory Improvement

Amendments (CLIA) program.

DATES: Effective Date: This notice is effective on August 27, 2010.

FOR FURTHER INFORMATION CONTACT: Raelene Perfetto, (410) 786-6876.

SUPPLEMENTARY INFORMATION:

  1. Background

    In a Federal Register notice published on February 23, 2007(72 FR 8171), we granted COLA approval as an accreditation organization under 42 CFR part 493 subpart E. The approval was effective from February 23, 2007 until February 25, 2013. During this time, COLA was allowed to accredit laboratories for purposes of establishing their compliance with CLIA requirements in the following specialty and subspecialty areas:

    Microbiology, including Bacteriology, Mycobacteriology,

    Mycology, Parasitology, Virology.

    Diagnostic Immunology, including Syphilis Serology,

    General Immunology.

    Chemistry, including Routine Chemistry, Urinalysis,

    Endocrinology, Toxicology.

    Hematology.

    Immunohematology, Including ABO Group and Rh Group,

    Antibody Detection, Antibody Identification, Compatibility Testing.

    Pathology, including Histopathology, Oral Pathology,

    Cytology.

    In a letter dated June 15, 2010, COLA provided official notice of its intent to voluntarily withdraw from accreditation in the specialty of Pathology. This withdrawal was effective June 30, 2010. All laboratories accredited by COLA in the specialty of Pathology (to include Histopathology, Oral Pathology or Cytology) will have 60 days from the date of this Federal Register notice to seek either CLIA inspection by the State Agency where the laboratory is located or accreditation with another accrediting organization that is currently

    CMS-approved for the specialty of Pathology.

    This notice only addresses COLA's accreditation for the specialty of Pathology. As discussed below, COLA's accreditation status in the other specialties is not affected by this notice.

  2. Provisions of the Notice

    This notice announces COLA's withdrawal as an accreditation organization from the specialty of Pathology. COLA retains deeming authority as an accreditation organization under 42 CFR part 493 subpart E in a number of specialties. It may continue to accredit laboratories for purposes of establishing their compliance with CLIA requirements in the following specialty and subspecialty areas:

    Microbiology, including Bacteriology, Mycobacteriology,

    Mycology, Parasitology, Virology.

    Diagnostic Immunology, including Syphilis Serology,

    General Immunology.

    Chemistry, including Routine Chemistry, Urinalysis,

    Endocrinology, Toxicology.

    Hematology.

    Immunohematology, including ABO Group and Rh Group,

    Antibody Detection, Antibody Identification, Compatibility Testing.

    1. Options for Laboratories Testing in Both Pathology and Other

      Specialties and Subspecialties

      Laboratories currently accredited by COLA and performing testing in both the specialty of Pathology (to include Histopathology, Oral

      Pathology, or Cytology) and the other specialties and subspecialties for which COLA retains deeming authority may choose one of the following courses of action:

      Remain with COLA for purposes of the accreditation of non-

      Pathology specialties and subspecialties only and seek accreditation services for Pathology from another CMS-approved accrediting organization. The Certificate of Accreditation (CoA) will remain.

      Seek certification for all applicable specialties and subspecialties from the State Agency where the laboratory is located. A laboratory may not combine accreditation from a CMS-approved accrediting organization with a certification from the State Agency where the laboratory is located. Laboratories must seek a single path, either accreditation through one or more accreditation organizations with the appropriate deeming authorities, or certification through the appropriate State Agency.

    2. Options for Laboratories Testing Only in Pathology

      Laboratories currently accredited by COLA and performing testing in only the specialty of Pathology (to include Histopathology, Oral

      Pathology or Cytology) have the following options:

      Seek CLIA accreditation with another CMS-approved accrediting organization that currently possesses deeming authority in the specialty of Pathology.

      Seek certification with the State Agency where the laboratory is located.

  3. Collection of Information Requirements

    This document does not impose information collection and recordkeeping requirements. Consequently, it need not be reviewed by the Office of Management and Budget under the authority of the

    Paperwork Reduction Act of 1995.

    Authority: Section 353 of the Public Health Service Act (42

    U.S.C. 263a).

    (Catalog of Federal Domestic Assistance Program No. 93.773,

    Medicare--Hospital Insurance Program; No. 93.774, Medicare--

    Supplementary Medical Insurance Program; and No. 93.778, Medical

    Assistance Program.)

    Dated: July 27, 2010.

    Donald M. Berwick,

    Administrator, Centers for Medicare & Medicaid Services.

    FR Doc. 2010-19675 Filed 8-10-10; 8:45 am

    BILLING CODE 4120-01-P